Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://okt.to/pVAtMg
Charles River Laboratories’ Post
More Relevant Posts
-
Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://okt.to/fdMHKX
Biobetter Development
pharmtech.com
To view or add a comment, sign in
-
Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://okt.to/t0sAgk
Biobetter Development
pharmtech.com
To view or add a comment, sign in
-
Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://okt.to/FztI3u
Biobetter Development
pharmtech.com
To view or add a comment, sign in
-
Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://bit.ly/3zBQopM
Biobetter Development
pharmtech.com
To view or add a comment, sign in
-
Learn more about the transformative potential of biobetters in this recent article featuring Ulrike Herbrand, PhD: https://okt.to/x5saW3
Biobetter Development
pharmtech.com
To view or add a comment, sign in
-
👋🏼 Hello toxicologists! We presented at #SOT2024 new data produced by our high-content screening system SydLab™ One for #DART The study highlights the strong advantages of SydLab™ One: 📊 Reproducible and accurate results thanks to standardized protocols 🧪 An automated dosing of chemicals with low liquid consumption 🚀 Multi-phenotypic readouts in real-time in full organisms 🔬 Fully automated high-content screening platform = unlocking #Celegans model as a new #NAMs technology for #EarlyTox SydLab™ One represents the first all-in-one C. elegans microfluidic #labdevice that contributes to the rapid identification of toxic compounds de-risking and accelerating the early stages of discovery pipelines. Missed our presentation? Download the poster here 🔗👉🏼 https://lnkd.in/eVDeJ5rz #toxicology #ReproTox #stressresponse #fluorescence #labtechnology #microfluidics #OoC #HCS #labautomation #AIanalysis
SOT 2024 Nagi Bioscience - Poster Download
nagibio.hubspotpagebuilder.com
To view or add a comment, sign in
-
Therapeutic Development: Clinical & Medical Affairs Consulting -Access to Commercialisation, Enabling
SMALL MOLECULE renaissance in 2023 Let's unpack the statement.... (i) Highly innovative, vertical small molecule technologies are maturing e.g. protein degraders (ii) Drugging the undruggable is becoming reality, with regulatory drug case studies (iii) Biopharma and Advanced Therapies have left in their wake a whole range of new druggable, undruggable targets and market opportunities (iv) Innovative small molecules are fast becoming the new disruptors (v) There is visible convergence between technologies e.g. ADCs (vi) Data Strategy and Quantitative Science is delivering new discovery targets, new models, new higher standards of quality (vii) Large pharma are increasingly dialing up their scientific policies, toolkits and capabilities (viii) Unmet rare diseases and new orphan drugs are becoming within reach (ix) Small molecules cross boundaries that disallow their larger cousins (x) etc etc... Seize the moment! #smallmolecules, #smallmolecule, #drugdiscovery, #drugdevelopment, #drugsafety, #drugdelivery, #medicinalchemistry #regulatoryaffairs #targetedproteindegradation #TPD #molecularglues #biopharma #biopharmaceuticals #biopharmaceutical
Rather than losing their attractiveness in the modern world of biological advances, small molecules are having something of a renaissance. There’s a buzz and a feeling that medicinal chemists can design solutions for diseases they once would have considered impossible to confront:
Why small-molecule drug discovery is having a moment
cen.acs.org
To view or add a comment, sign in
-
Great new article on the exciting current state of play in small molecule drug discovery — and even features a couple of snippets from me! (I guess I’ve also now crossed “quoted in C&EN” off my bucket list.)
Rather than losing their attractiveness in the modern world of biological advances, small molecules are having something of a renaissance. There’s a buzz and a feeling that medicinal chemists can design solutions for diseases they once would have considered impossible to confront:
Why small-molecule drug discovery is having a moment
cen.acs.org
To view or add a comment, sign in
-
Interesting to read why small molecules are having something of a renaissance.
Rather than losing their attractiveness in the modern world of biological advances, small molecules are having something of a renaissance. There’s a buzz and a feeling that medicinal chemists can design solutions for diseases they once would have considered impossible to confront:
Why small-molecule drug discovery is having a moment
cen.acs.org
To view or add a comment, sign in